1. Home
  2. ULS vs MEDP Comparison

ULS vs MEDP Comparison

Compare ULS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UL Solutions Inc.

ULS

UL Solutions Inc.

N/A

Current Price

$81.69

Market Cap

14.5B

Sector

N/A

ML Signal

N/A

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

N/A

Current Price

$665.84

Market Cap

17.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ULS
MEDP
Founded
1894
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5B
17.2B
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
ULS
MEDP
Price
$81.69
$665.84
Analyst Decision
Buy
Hold
Analyst Count
13
14
Target Price
$96.45
★ $651.31
AVG Volume (30 Days)
★ 870.0K
301.9K
Earning Date
11-03-2026
10-21-2026
Dividend Yield
★ 0.71%
N/A
EPS Growth
N/A
★ 20.98
EPS
2.19
★ 13.37
Revenue
★ $3,053,000,000.00
N/A
Revenue This Year
$7.16
$12.62
Revenue Next Year
$9.29
$6.03
P/E Ratio
★ $37.09
$49.82
Revenue Growth
★ 6.38
N/A
52 Week Low
$63.17
$373.00
52 Week High
$107.54
$693.97

Technical Indicators

Market Signals
Indicator
ULS
MEDP
Relative Strength Index (RSI) 68.02 55.31
Support Level $81.10 $575.64
Resistance Level $83.93 $685.94
Average True Range (ATR) 3.24 20.42
MACD 0.66 -1.35
Stochastic Oscillator 87.45 50.11

Price Performance

Historical Comparison
ULS
MEDP

About ULS UL Solutions Inc.

UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: